Leptin production is increased in rodents by administration of endotoxin or cytokines. To investigate whether circulating leptin is related to cytokine release and survival in human sepsis, plasma concentrations of leptin, interleukin (IL)-6, IL-1b, tumor necrosis factor (TNF)-a, soluble TNF receptor type I, IL-1 receptor antagonist (IL-1ra), and the inflammatory modulator IL-10 were measured as soon as severe sepsis ( ) or septic shock n ϭ 28 ( ) developed and every 6 h for 24 h. Patients with sepsis or septic shock had leptin n ϭ 14 concentrations 2.3-and 4.2-fold greater, respectively, than the control group. There was an independent association for leptin with IL-1ra and IL-10 in both patient groups. By discriminant analysis, leptin and IL-6 were independent predictors of death. These findings suggest that increases in leptin levels may be a host defense mechanism during sepsis.
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Excessive production of proinflammatory cytokines, including interleukin (IL)-6, tumor necrosis factor (TNF)-a, and IL1b, plays a major role in the initiation of the sepsis syndrome [1] , and the amount and speed of their release correlates with the occurrence of septic shock and, eventually, with mortality [2] . However, TNF-a and IL-1b are seldom found in the circulation of septic patients. It has been proposed that enhanced production of endogenous inhibitors of these cytokines, such as soluble TNF-a receptor I (sTNF-RI) [3] and IL-1 receptor antagonist (IL-1ra) [4] , as well as increased secretion of the antiinflammatory cytokine IL-10 [5, 6] may be important host defense mechanisms to attenuate concurrent proinflammatory cytokine activity during sepsis [6] .
Serum leptin levels are increased in rodents by administration of endotoxin or cytokines [7, 8] . Increased serum leptin concentrations have been found in patients with cancer, after intravenous administration of TNF-a or IL-1b [9, 10] . Recently, increased plasma concentrations of leptin and IL-6 were reported in 16 patients with acute sepsis, and the highest leptin levels on admission were found in patients who survived [11] .
However, that study only included sequential measurements over 24 h in half the patients, and IL-6 was the single cytokine assayed. To our knowledge, no studies have sought to sequentially measure plasma concentrations of leptin and some components of the proinflammatory and antiinflammatory cytokine response in human sepsis. We hypothesized that persons with sepsis and septic shock would have circulating leptin concentrations higher than that expected, on the basis of their body fat mass. Furthermore, we postulated that circulating leptin might be related to the extent of activation of the immune system and might serve as a marker of the severity and outcome for persons with sepsis.
Materials and Methods

Patients.
We studied 42 critically ill patients with cultureproven bacteremia (positive blood cultures for gram-positive cocci, 12; for gram-negative bacilli, 25; for polymicrobial infection, 8) , who met the diagnostic criteria for either severe sepsis or septic shock by recent consensus conference definition [12] . None had malignant or chronic inflammatory diseases. Patients were classified into 2 groups: group 1 was composed of 28 patients with severe sepsis admitted to departments of internal medicine or intensive care and treated with broad-spectrum antibiotics and conservative measures. Group 2 included 14 patients with septic shock who were treated with mechanical ventilation, broad-spectrum antibiotics, adequate fluid resuscitation, and vasopressor drugs. Plasma samples were taken within 48 h after blood culture collection, at the time of onset of systolic hypotension or septic shock, and every 6 h for 24 h. The control group was composed of 20 subjects before elective surgery for complicating peptic ulcer. The controls had normal serum concentrations of orosomucoid (reference value !1.1 g/L Ϫ1 ) at time of blood sampling, to exclude an ongoing acutephase reaction. ]) was calculated for subjects at study enrollment. Body fat mass was determined by tetrapolar bioelectric impedance (Human-IM Scan; Ditosystem, Barcelona, Spain), measured at 50 kHz in the subset of surviving patients with sepsis and in control subjects. Leptin concentrations were determined by RIA (Linco Research, St. Charles, MO; intra-assay coefficient of variance [CV] of 3.5%-8.5% and a sensitivity of 0.5 ng/mL). IL-6 and IL-10 were determined by an ELISA (Medgenix Diagnostics, Fleurus, Belgium), and concentrations of sTNF-RI and IL-1ra were measured by a quantitative sandwich ELISA (Quantikine; R&D Systems, Minneapolis). All assays were performed in duplicate. Detection limits of the assays were 8 (IL-6), 12 (IL-10), 90 (sTNF-RI), and 250 (IL-1ra) pg/mL. All cytokine assays had intra-and interassay CVs lower than 8% and 10%, respectively.
Statistical analysis. BMI and the acute physiology and chronic health evaluation (APACHE) II score at the onset of sepsis or septic shock are expressed as . The data for plasma lactate mean ‫ע‬ SD and cytokines concentrations were analyzed for normality by use of a Shapiro-Wilk test (SAS Institute, Cary, NC). Mean leptin and cytokine values were tabulated by adding serial values and by dividing the total number of determinations by 4. Data are presented as geometric means and extremes. Comparisons were performed by one-way analysis of variance on log-transformed data, to reduce positive skewness. Scheffé's simultaneous confidence intervals were determined to account for multiple comparisons. A stepwise regression analysis (stepping up, using 0.05 as the criteria for inclusion in the model) was used to identify associations between leptin and cytokine concentrations. Logistic discriminant analysis was used to compare surviving and nonsurviving patients from a multivariate standpoint and to determine, in a stepwise manner, which variables were most predictive of mortality. [7.4-14.7 ] ng/mL, ). Similar differences between both dis-P ! .01 ease states and the control group were found when the leptin/ BMI ratio was calculated as an indirect way of correcting for adiposity (table 1) . In addition, when all surviving patients with sepsis ( ) were reevaluated after recovery, their plasma n ϭ 18 leptin values (4.8 [2.7.-6.5] ng/mL) had returned to the normal range. Compared with controls ( kg of body fat cal-12.4 ‫ע‬ 0.6 culated by bioelectrical impedance), surviving patients had similar body fat mass ( kg). No difference in leptin per 12.6 ‫ע‬ 0.5 unit of adiposity was observed in the 2 groups ( ng/ 0.35 ‫ע‬ 0.02 kg for controls and ng/kg for patients). 0.39 ‫ע‬ 0.03 Sepsis patients had cytokine concentrations notably lower than in septic shock patients. Leptin, IL-1ra, and IL-10 levels were significantly higher in survivors with sepsis or septic shock than in nonsurvivors; mean IL-6 levels were lower in survivors than in nonsurvivors, and the mean sTNF-RI concentration was significantly higher only in septic shock survivors (figure 1).
Results
The
Significant linear correlations were found between log transformed leptin values and the logarithmic values of IL-1ra Stepwise r ϭ .656 P ! .0001 r ϭ .551 P ! .0001 regression analysis in all patients ( ) indicated that log n ϭ 42 IL-1ra ( , ; ) and log IL-10 ( b ϭ 0.418 SE ϭ 0.05 P ! .001 b ϭ , , ) were significantly associated with 0.114 SE ϭ 0.044 P ! .014 log leptin. As criteria for classifying patients into survivors and nonsurvivor groups, the stepwise discriminant analysis revealed that log leptin and log IL-6 (standardized discriminant function coefficients: Ϫ2.101 and 1.174, respectively) were the variables selected with 95% of correct jackknifed classification.
Discussion
In accordance with a previous report of high plasma leptin concentrations in critically ill patients [11] , we found that patients with severe sepsis and septic shock had leptin concentrations 2.3-and 4.2-fold greater, respectively, than the control group. However, because their BMIs were not statistically different from controls, there was a lack of correlation between leptin in the circulation and body fat stores in these patients. Thus, the primary role of leptin in patients with sepsis and septic shock does not seem to indicate the magnitude of energy stores to the brain, but rather a stress-related peptide. Survivors of severe sepsis and septic shock had leptin concentrations 1.3-and 1.6-fold greater than nonsurvivors in each group, whereas mean leptin concentration was 1.3-fold higher in surviving patients, when both disease states were considered together. The higher leptin plasma concentrations that we found in survivors with sepsis and septic shock might represent a host defense mechanism against bacterial infection. In fact, in vitro studies have revealed that leptin stimulates proliferation of lymphohematopoetic cells and phagocytic activity of macrophages [13] .
Our findings of higher plasma concentrations of IL-6, sTNF-RI, IL-1ra, and IL-10 in patients with acute sepsis, compared with the control group, and markedly higher levels in persons with septic shock than in sepsis patients without shock confirms and extends the results of previous studies [14, 15] . Of interest, we found a highly significant positive association between circulating concentrations of leptin and IL-1ra and IL-10 in patients with severe sepsis and in those with septic shock. Circulating levels of sTNF-RI is thought to reflect more accurately the degree of activation of the TNF-a system than circulating levels of TNF-a [3] . IL-1ra is an effective inhibitor of IL-1b in vitro systems [4] , whereas IL-10 inhibits several functions of macrophages/monocytes, including the endotoxin-induced production of proinflammatory cytokines [5] . Therefore, the high plasma concentrations of sTNF-RI, IL-1ra, and IL-10 that we found in patients with sepsis and septic shock may indirectly reflect enhanced TNF-a and IL-1b production and may be indicative of an ongoing cytokine response.
In summary, our data show that high leptin and low IL-6 levels in patients with sepsis and septic shock are significantly associated with less mortality. These might serve as surrogate markers of a protective and relatively smoother immune response.
